PACB 1.17 (-2.5%)
US69404D1081• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PACB

Pacific Biosciences of California (PACB) Competitor Comparison

We are evaluating the key criteria listed to compare Pacific Biosciences of California (PACB) against its competitors in the Diagnostics & Research industry.

Market Capitalization

30 / 58

Gross Profits

38 / 52

Total Revenue

36 / 57

EBITDA

54 / 56

Free Cashflow

49 / 56

Quick Ratio

16 / 57

Earnings per Share

44 / 56

Dividend yield

0 / 9

Total Cash

11 / 57

Performance 3 years

47 / 58

Performance 5 years

34 / 58

Performance 10 years

40 / 58

Linearity 3 years

32 / 58

Linearity 5 years

12 / 58

Linearity 10 years

15 / 58

Total Rank

57 / 58

Dividend Rank

28 / 58

Valuation Rank

47 / 58

Piotroski Rank

54 / 58

Muliplier Rank

28 / 58

Linearity 10 years - PACB ranking 15 / 58

These are the competitors of Pacific Biosciences of California in the industry Diagnostics & Research ranked by linearity 10 years
1. Ortho Clinical Diagnostics Holdings OCDX
33.4
2. Inotiv NOTV
25.73
3. National Research NRC
25.5
4. Charles River Laboratories CRL
15.23
5. Anixa Biosciences ANIX
8.7
6. Olink Holding OLK
8.11
7. Guardant Health GH
7.93
8. NeoGenomics NEO
7.14
9. Neogen NEOG
5.68
10. Global Cord Blood CO
5.67
11. Illumina ILMN
5.23
12. Exact Sciences EXAS
5.06
13. Fulgent Genetics FLGT
4.94
14. DarioHealth DRIO
4.86
15. Pacific Biosciences of California PACB
4.63
16. Qiagen QGEN
3.96
17. Syneos Health SYNH
3.71
18. Icon ICLR
3.57
19. Sotera Health SHC
3.44
20. Co-Diagnostics CODX
3.21
21. Twist Bioscience TWST
3.1
22. Enzo Biochem ENZ
3.08
23. IQVIA Holdings IQV
2.96
24. Myriad Genetics MYGN
2.9
25. Bioventus BVS
2.76
26. Psychemedics PMD
2.42
27. Sera Prognostics SERA
2.37
28. CareDx CDNA
2.33
29. Exagen XGN
2.31
30. Aspira Womens Health AWH
2.28
31. Agilent Technologies A
2.18
32. Meridian Bioscience VIVO
2.1
33. Laboratory Corp of America Holdings LH
1.95
34. MDxHealth MDXH
1.91
35. bioAffinity Technologies BIAF
1.9
36. Biodesix BDSX
1.87
37. Personalis PSNL
1.79
38. MaxCyte MXCT
1.79
39. Prenetics Global PRE
1.7
40. DexCom DXCM
1.68
41. Organovo Holdings ONVO
1.66
42. Neuronetics STIM
1.62
43. Quest Diagnostics DGX
1.59
44. Trinity Biotech TRIB
1.57
45. Mettler-Toledo MTD
1.51
46. SeqLL SQL
1.42
47. Waters WAT
1.41
48. Danaher DHR
1.39
49. Thermo Fisher Scientific TMO
1.38
50. Interpace Biosciences IDXG
1.33
51. PerkinElmer PKI
1.15
52. Precipio PRPO
1.09
53. IDEXX Laboratories IDXX
1.03
54. Heska HSKA
0.52
55. Natera NTRA
0.4
56. Lantheus Holdings LNTH
0.33
57. RadNet RDNT
0.29
58. Medpace Holdings MEDP
0.25
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.